Kevin Laliberte, Senior VP, Product Development at Dova Pharmaceuticals Inc. (DOVA), sold 3,100 shares at $20.00 ($62K) on 2019-09-25, disclosed to the SEC on 2019-09-27.
Open-market sale of $62k DOVA by Senior VP, Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DOVA | SELL | 2019-07-02 | $17K | — | Filing → |
| DOVA | BUY | 2017-07-07 | $105K | — | Filing → |